Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Distribution of Data: The Central Limit Theorem: Using the central limit theorem concerning the distribution of means allows one to justify the assumption of the normal distributionPharmaceutical technology Europe, 2019-10, Vol.31 (10), p.50 [Peer Reviewed Journal]COPYRIGHT 2019 UBM LLC ;ISSN: 1753-7967Full text available |
|
2 |
Material Type: Article
|
Implementation of Autocorners Algorithm for Retrospective Process Monitoring: Process variability must be assessed over time to ensure that pharmaceutical product quality is maintained. While the application of prospective statistical process control has been widely published, much less emphasis has been given to retrospective statistical analysis and associated methods and approaches. The authors present a simple-to-use Microsoft Excelbased statistical tool that uses cumulative sum techniques tPharmaceutical technology Europe, 2020-03, Vol.32 (3), p.19 [Peer Reviewed Journal]COPYRIGHT 2020 Intellisphere, LLC ;ISSN: 1753-7967Full text available |
|
3 |
Material Type: Article
|
The Search for Transparency in Excipient Sourcing: Researching excipient grades and sources, as well as screening suppliers and materials, form the basis of programmes to mitigate riskPharmaceutical technology Europe, 2020-02, Vol.32 (2), p.14 [Peer Reviewed Journal]COPYRIGHT 2020 Intellisphere, LLC ;ISSN: 1753-7967Full text available |
|
4 |
Material Type: Article
|
PRODUCT/SERVICE PROFILESPharmaceutical technology Europe, 2018-07, Vol.30 (7), p.41-41 [Peer Reviewed Journal]Copyright UBM Americas Jul 2018 ;ISSN: 1753-7967Full text available |
|
5 |
Material Type: Article
|
Utilizing Spectral Analysis in HPLC Diode Array to Discover ImpuritiesPharmaceutical technology Europe, 2019-03, p.S4-S6 [Peer Reviewed Journal]Copyright UBM Americas Mar 2019 ;ISSN: 1753-7967Full text available |
|
6 |
Material Type: Article
|
Global end-to-end healthcare solutionsPharmaceutical technology Europe, 2017-07, Vol.29 (7), p.47 [Peer Reviewed Journal]COPYRIGHT 2017 UBM LLC ;ISSN: 1753-7967Full text available |
|
7 |
Material Type: Article
|
pH adjustment in pharmaceutical productionPharmaceutical technology Europe, 2017-07, Vol.29 (7), p.48 [Peer Reviewed Journal]COPYRIGHT 2017 UBM LLC ;ISSN: 1753-7967Full text available |
|
8 |
Material Type: Article
|
Counting on Pharma for an Exciting Yead AheadPharmaceutical technology Europe, 2015-01, Vol.27 (1), p.6 [Peer Reviewed Journal]Copyright Advanstar Communications, Inc. Jan 2015 ;ISSN: 1753-7967Full text available |
|
9 |
Material Type: Article
|
Catalent Pharma SolutionsPharmaceutical technology Europe, 2017-01, Vol.29 (1), p.47 [Peer Reviewed Journal]COPYRIGHT 2017 MJH Life Sciences Media ;ISSN: 1753-7967Full text available |
|
10 |
Material Type: Article
|
Rommelag CMO, works Holopack Verpackungstechnik GmbHPharmaceutical technology Europe, 2017-01, p.48 [Peer Reviewed Journal]COPYRIGHT 2017 UBM LLC ;ISSN: 1753-7967Full text available |
|
11 |
Material Type: Article
|
Poseidon Takes on The Pharma Supply Chain: Lower costs, fewer opportunities for temperature excursions, and a smaller carbon footprint are making ocean transport more attractive for pharmaceuticals. Poseidon, a new collaborative pharma initiative, seeks to leverage benefitsPharmaceutical technology Europe, 2018-03, Vol.30 (3), p.44 [Peer Reviewed Journal]COPYRIGHT 2018 UBM LLC ;ISSN: 1753-7967Full text available |
|
12 |
Material Type: Article
|
Small-Molecule Drug Development ServicesPharmaceutical technology Europe, 2020-03, Vol.32 (3), p.40 [Peer Reviewed Journal]COPYRIGHT 2020 Intellisphere, LLC ;ISSN: 1753-7967Full text available |
|
13 |
Material Type: Article
|
Catalent Pharma SolutionsPharmaceutical technology Europe, 2016-12, Vol.28 (12), p.52 [Peer Reviewed Journal]COPYRIGHT 2016 MJH Life Sciences Media ;ISSN: 1753-7967Full text available |
|
14 |
Material Type: Article
|
Baxter BioPharma SolutionsPharmaceutical technology Europe, 2016-12, p.51 [Peer Reviewed Journal]COPYRIGHT 2016 UBM LLC ;ISSN: 1753-7967Full text available |
|
15 |
Material Type: Article
|
TASI TEST-Sepha, Bonfiglioli ALPSPharmaceutical technology Europe, 2016-12, p.62 [Peer Reviewed Journal]COPYRIGHT 2016 UBM LLC ;ISSN: 1753-7967Full text available |
|
16 |
Material Type: Article
|
Rommelag CMOPharmaceutical technology Europe, 2016-12, p.58 [Peer Reviewed Journal]COPYRIGHT 2016 UBM LLC ;ISSN: 1753-7967Full text available |
|
17 |
Material Type: Article
|
Letzner Pharmawasseraufbereitung GmbhPharmaceutical technology Europe, 2016-12, p.55 [Peer Reviewed Journal]COPYRIGHT 2016 UBM LLC ;ISSN: 1753-7967Full text available |
|
18 |
Material Type: Article
|
B. Braun MelsungenPharmaceutical technology Europe, 2016-12, p.50 [Peer Reviewed Journal]COPYRIGHT 2016 UBM LLC ;ISSN: 1753-7967Full text available |
|
19 |
Material Type: Article
|
Striking a Landmark Deal: After years of discussions around pricing, UK governmental bodies and Vertex have finally reached an agreement on cystic fibrosis treatmentsPharmaceutical technology Europe, 2019-11, Vol.31 (11), p.6 [Peer Reviewed Journal]COPYRIGHT 2019 Intellisphere, LLC ;ISSN: 1753-7967Full text available |
|
20 |
Material Type: Article
|
The Big Deal Behind the 'No-Deal' Scenario: As a potential 'no-deal' Brexit looms, pharma companies and industry bodies are preparing for the worst-case scenario but hoping that the UK won't end up with a disorderly exit from the EUPharmaceutical technology Europe, 2019-09, Vol.31 (9), p.46 [Peer Reviewed Journal]COPYRIGHT 2019 UBM LLC ;ISSN: 1753-7967Full text available |